Ariana Boswell

All articles by Ariana Boswell

• J&J publishes easy to understand summary of nipocalimab trial

  The summary describes the design of Johnson & Johnson’s Phase 3 AZALEA trial, which will evaluate the efficacy of nipocalimab in HDFN.

• Pre-hospital blood transfusion program in California reduced HDFN mortality

  A blood transfusion protocol used in Los Angeles results in fewer deaths due to HDFN than other protocols.

• Targeted RhD immune globulin approach can help current shortage

  The United States is experiencing a shortage of RhD immune globulin, indicating a need for novel strategies to prevent HDFN.

• Case report: Rare RhD antigen variant found in patient

  A recent case report describes a 63-year-old woman in China who was diagnosed with a rare variant of the RhD antigen.

• Review: Global disparities in HDFN mortality persist

  A study identified several societal factors contributing to the disparity in infant mortality due to HDFN and other hemolytic disorders.

• New study to assess potential indicator of HDFN recruiting patients

  A new observational study in China aims to evaluate the utility of neonatal carbon monoxide concentrations in diagnosing and treating HDFN.

• Rare Disease Day: Why it matters and how to get involved

  Rare Disease Day 2025 aims to uplift the rare disease community and promote greater awareness.

• Elevated bilirubin levels in umbilical cord could be an early predictor of HDFN

  Neonates with HDFN who had high cord bilirubin levels were more likely to require phototherapy and exchange transfusion, a study found.

• Study shows guidelines vary for RhD testing and prophylaxis

  A recent study revealed variations in international guidelines on RhD testing and prophylaxis, demonstrating the need for further research.

• Researchers update guidelines for monitoring antibodies in HDFN

  Researchers updated the 2016 guidelines for evaluating blood antibodies in HDFN in order to improve diagnosis and fetal outcomes.